Riverstone reported 4Q FY2025 revenue of MYR250.7 million, up 1.3% q-o-q and down 9.8% y-o-y, while net profit rose 3.7% q-o-q to MYR54.0 million (down 23% y-o-y). Gross profit in 4Q FY2025 fell 3% q-o-q to MYR74.2 million, with gross margin at 29.6% (down 1.3 ppts q-o-q), which the group attributed mainly to foreign exchange impact from a stronger Malaysian ringgit against the US dollar. For FY2025, Riverstone posted revenue of MYR995.3 million (down 7.2% y-o-y), profit before tax of MYR264.5 million (down 26.3% y-o-y) and net profit of MYR207.8 million (down 27.6% y-o-y), with diluted EPS at 14.02 sen (down 27.6% y-o-y). The company proposed a final dividend of 5.0 sen per share and a special dividend of 4.0 sen, taking FY2025 total dividends to 17.0 sen and implying a 121.3% payout and a 6.9% yield. Management said cleanroom glove demand remained resilient, supported by AI infrastructure-related expansion, while Riverstone stayed focused on cleanroom and customised healthcare gloves and remained selective in generic healthcare amid a more competitive environment; it also flagged ongoing FX fluctuations and a temporary hike in raw material costs, expected to normalise from 2Q FY2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Riverstone Holdings Limited published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: CFHRYKDKKVLRWJZW) on February 25, 2026, and is solely responsible for the information contained therein.